Opiant Pharmaceuticals (NASDAQ: OPNT) reported Q2 EPS of $0.31, $0.86 better than the analyst estimate of ($0.55). Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE